Last update 16 Dec 2024

BOS-172722

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
BOS172722, CCT-289346
Target
TTK
Mechanism
TTK inhibitors(Dual specificity protein kinase TTK inhibitors)
Therapeutic Areas
NeoplasmsSkin and Musculoskeletal Diseases
Active Indication
Breast Cancer
Inactive Indication
Triple Negative Breast Cancer
Originator Organization
Hemostemix Asia, Inc.
Active Organization
The Institute of Cancer Research: Royal Cancer HospitalThe Institute of Cancer Research: Royal Cancer Hospital
Inactive Organization
Boston Pharmaceuticals, Inc.Boston Pharmaceuticals, Inc.Startup
Drug Highest PhasePhase 1
First Approval Date-
Regulation-
Login to view timeline

Structure

Molecular FormulaC24H30N8O
InChIKeySGWLRDAOCLITOM-UHFFFAOYSA-N
CAS Registry1578245-44-9

Related

1
Clinical Trials associated with BOS-172722
NCT03328494 / CompletedPhase 1
A Phase 1/1b Study of Paclitaxel in Combination With BOS172722, a Monopolar Spindle 1 Kinase Inhibitor, in Patients With Advanced Nonhaematologic Malignancies
100 Clinical Results associated with BOS-172722
Login to view more data
100 Translational Medicine associated with BOS-172722
Login to view more data
100 Patents (Medical) associated with BOS-172722
Login to view more data
100 Deals associated with BOS-172722
Login to view more data

External Link

KEGGWikiATCDrug Bank
---
DB15498

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Breast CancerPhase 1
GB
The Institute of Cancer Research: Royal Cancer HospitalThe Institute of Cancer Research: Royal Cancer Hospital
30 Jan 2023
Triple Negative Breast CancerPhase 1
GB
Boston Pharmaceuticals, Inc.Boston Pharmaceuticals, Inc.Startup
13 Oct 2017
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free